STVN

Stevanato Group S.p.A. Ordinary Shares (STVN)

Stock · NYSE · Health Care

$18.9as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Stevanato Group joins Ensera alliance with medical device partners. Stevanato Group has joined a new alliance network led by Ensera, alongside partners like SHL Medical and Ypsomed. This move aims to strengthen collaboration within the medical device supply chain. The stock is currently trading near its support level, with an average analyst target of $24.68.

Active signals

Support level
$17.81
Industry
Medical/Dental Instruments

What STVN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike45+0.7%51%
Bollinger Band Breakout29-1.4%38%
200-Day Moving Average TouchActive now21+0.1%52%
Bollinger Band Breakdown16+0.7%56%
Any 20-session window (baseline)+1.0%54%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About STVN

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syrin…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
6,010

Fundamentals

1-day range
$18.51$19.27
Market cap
$6.14B
P/E (trailing)
34.82
P/E (forward)
22.55
EPS (trailing)
$0.49
Dividend yield
0.21%
Beta
0.76
Avg. volume
377.3K
Ex-dividend date
June 11, 2026
Dividend pay date
July 29, 2026
52-week range
$12.89$27.99
Next earnings: November 5, 2026 · EPS estimate $0.18Before Openconfirmed

Forecasts

13 analyst ratings

Buy 78%
Hold 22%
Sell 0%
1-year price forecast
High
$32
+69.3%
Median
$25
+32.3%
Low
$20
+5.8%

Stevanato Group S.p.A. Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • STVN
    Stevanato Group S.p.A. Ordinary Shares
    $18.9
    ▼ 1.82%
    Market cap $6.14BP/E 34.82
    $12.89$27.99
  • TFX
    Teleflex Incorporated Common Stock
    $130.43
    ▲ 1.72%
    Market cap $6.15BP/E —
    $100.18$145
  • MMSI
    Merit Medical Systems Inc. Common Stock
    $89.2
    ▼ 0.41%
    Market cap $5.24BP/E 36.33
    $59.74$94.75
  • MMED
    MiniMed Group Inc. Common Stock
    $17.49
    ▼ 2.83%
    Market cap $5.17BP/E —
    $10.65$24.43
  • NVST
    Envista Holdings Corporation Common Stock
    $22.9
    ▼ 2.55%
    Market cap $4.46BP/E 39.56
    $18.77$30.42
  • IRTC
    iRhythm Holdings Inc. Common Stock
    $108.66
    ▼ 0.63%
    Market cap $4.21BP/E —
    $100.7$212
  • ICUI
    ICU Medical Inc. Common Stock
    $162.99
    ▼ 2.54%
    Market cap $4.16BP/E 139.19
    $113.37$192.85

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
25.3K
Disposed
22.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.